O-GlcNAc transferase (OGT) is an essential mammalian enzyme that catalyzes a unique post-translational modification, O-GlcNAcylation. O-GlcNAcylation has been shown to modulate insulin signaling, gluconeogenesis, and other pathways connected to glucose metabolism. Hyper-O-GlcNAcylation leads to widespread transcriptional changes and has been linked to diabetic complications, cancer, and other pathologies. Therefore, it has been suggested that OGT could be a therapeutic target. A better understanding of the structure and function of OGT is critical for dissecting its biological roles, and small molecule inhibitors are widely sought by the scientific community. The goals of this proposal are i) to supply the structural basis for rational experiments to dissect the biochemical and cellular functions of OGT, ii) to provide validated small molecule inhibitors for use as cellular probes of OGT function, and iii) to develop a proteome-wide substrate profiling approach to identify OGT features required for substrate selection.

Public Health Relevance

O-GlcNAc transferase (OGT) is an essential mammalian enzyme that catalyzes a unique post-translational modification, O-GlcNAcylation. This modification mediates critical cellular processes involved in nutrient signaling, stress responses, and cell division. Aberrant O-GlcNAcylation has been linked to many diseases, and the work proposed here will lead to the development of small molecule inhibitors to probe OGT's biological roles and potential as a therapeutic target.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM094263-04
Application #
8796187
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Marino, Pamela
Project Start
2012-02-01
Project End
2016-01-31
Budget Start
2015-02-01
Budget End
2016-01-31
Support Year
4
Fiscal Year
2015
Total Cost
$517,469
Indirect Cost
$210,295
Name
Harvard Medical School
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Levine, Zebulon G; Fan, Chenguang; Melicher, Michael S et al. (2018) O-GlcNAc Transferase Recognizes Protein Substrates Using an Asparagine Ladder in the Tetratricopeptide Repeat (TPR) Superhelix. J Am Chem Soc 140:3510-3513
Martin, Sara E S; Tan, Zhi-Wei; Itkonen, Harri M et al. (2018) Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors. J Am Chem Soc 140:13542-13545
Janetzko, John; Walker, Suzanne (2017) Aspartate Glycosylation Triggers Isomerization to Isoaspartate. J Am Chem Soc 139:3332-3335
Janetzko, John; Trauger, Sunia A; Lazarus, Michael B et al. (2016) How the glycosyltransferase OGT catalyzes amide bond cleavage. Nat Chem Biol 12:899-901
Itkonen, Harri M; Gorad, Saurabh S; Duveau, Damien Y et al. (2016) Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism. Oncotarget 7:12464-76
Levine, Zebulon G; Walker, Suzanne (2016) The Biochemistry of O-GlcNAc Transferase: Which Functions Make It Essential in Mammalian Cells? Annu Rev Biochem 85:631-57
Angelova, Magdalena; Ortiz-Meoz, Rodrigo F; Walker, Suzanne et al. (2015) Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus. J Virol 89:8474-83
Ortiz-Meoz, Rodrigo F; Jiang, Jiaoyang; Lazarus, Michael B et al. (2015) A small molecule that inhibits OGT activity in cells. ACS Chem Biol 10:1392-7
Ortiz-Meoz, Rodrigo F; Merbl, Yifat; Kirschner, Marc W et al. (2014) Microarray discovery of new OGT substrates: the medulloblastoma oncogene OTX2 is O-GlcNAcylated. J Am Chem Soc 136:4845-8
Sherman, David J; Lazarus, Michael B; Murphy, Lea et al. (2014) Decoupling catalytic activity from biological function of the ATPase that powers lipopolysaccharide transport. Proc Natl Acad Sci U S A 111:4982-7

Showing the most recent 10 out of 15 publications